Universal Biosensors Inc (UVBIF)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

1 CORPORATE AVENUE VICTORIA, AUSTRALIA 3178

Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty, Ltd., operates as a medical diagnostics company primarily in Australia. It focuses on the development, manufacture, and commercialization of a range of in vitro diagnostic tests for point-of-care use. The company is developing various point-of-care blood tests, including C-reactive protein test which is an immunoassay blood test that detects and quantifies the level of C-reactive protein in the body; and Prothrombin time test that is used for monitoring the therapeutic range of the long-term anticoagulant, warfarin. It also engages in the contractual product development of a blood glucose test for third party.

View SEC Filings from UVBIF instead.
Q2 2019 All Institutions Hedge Funds 1
To trade UVBIF now:
No data found for this quarter.
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding UVBIF (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

3.6 Million total shares from 4 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COLEMAN CRAIG E.

  • Director
  • 10% Owner
33,930,445 2019-09-11 1

VF STRATEGIC EQUITIES FUND

  • 10% Owner
21,882,335 2019-09-11 1

HEINBERG MARSHALL

  • Director
6,610 2019-08-20 0

BALAK SALESH CHIEF FINANCIAL OFFICER

  • Officer
201,558 2019-05-29 2

CVC LTD

  • 10% Owner
23,820,765 2019-03-05 5

OATES ADRIAN SEE REMARKS

  • Officer
291,837 2019-02-28 2

LEGLEITER RICK L CHIEF EXECUTIVE OFFICER

  • Officer
162,853 2018-12-14 1

JOHNSON & JOHNSON

JOHNSON & JOHNSON INNOVATION - JJDC, INC.

  • 10% Owner
No longer subject to file 2018-07-19 0

VF HIGH CONVICTION FUND

  • 10% Owner
11,823,530 2018-05-09 0

HOEY DAVID L

  • Director
566,414 2018-03-15 0

HODGES ALASTAIR CHIEF SCIENTIST

  • Officer
2,871,615 2017-10-24 0

CHAMBERS GARRY VP TECHNOLOGY DEVELOPMENT

  • Officer
2,275,594 2017-10-24 0

SMITH JUDITH ANN DIRECTOR

  • Officer
100,000 2017-02-14 0

VF AUSTRALIAN EQUITIES FUND

  • 10% Owner
0 2016-12-02 0

WRIGHT PAUL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
800,591 2015-07-09 0

DENVER ANDREW

  • Director
8,076,955 2014-05-14 0

HANLEY DENIS

  • Director
7,589,766 2014-05-14 0

SMITH CHRISTOPHER M

  • Director
30,000 2014-05-06 0

DAVIS FREDERICK HARRY VP BUSINESS DEVELOPMENT

  • Officer
31,704 2013-12-12 0

WILSON ELIZABETH

  • Director
2,035,944 2012-12-18 0

ADAM COLIN

  • Director
5,626,951 2010-08-11 0

MORRISSON MARK MANAGING DIRECTOR/C.E.O.

  • Officer
  • Director
13,081 2010-05-25 0

KIEFEL CHARLES

  • Director
5,963,005 2008-06-04 0

CM CAPITAL VENTURE TRUST NO. 3

  • 10% Owner
17,794,384 2007-12-12 0

JANE ANDREW

  • Director
  • 10% Owner
17,794,384 2007-12-12 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

COLEMAN CRAIG E. - Director - > 10% Owner by partnership

2019-09-12 P 80,000 $0.19 a 33,710,445 33,930,445.00 indirect

VF STRATEGIC EQUITIES FUND - > 10% Owner

2019-09-12 P 80,000 $0.19 a 21,882,335 21,882,335.00 direct

COLEMAN CRAIG E. - Director - > 10% Owner by partnership

2019-09-11 P 1,710,683 $0.19 a 33,630,445 33,930,445.00 indirect

VF STRATEGIC EQUITIES FUND - > 10% Owner

2019-09-11 P 1,710,683 $0.19 a 21,802,335 21,882,335.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments